These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 32294495)
1. Chloroquine as a prophylactic agent against COVID-19? Gendrot M; Javelle E; Clerc A; Savini H; Pradines B Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495 [TBL] [Abstract][Full Text] [Related]
2. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19. Principi N; Esposito S Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322 [No Abstract] [Full Text] [Related]
3. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance. Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Shah S; Das S; Jain A; Misra DP; Negi VS Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213 [TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine prophylaxis for COVID-19 contacts in India. Rathi S; Ish P; Kalantri A; Kalantri S Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324 [No Abstract] [Full Text] [Related]
6. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Sargin G; Yavaşoğlu Sİ; Yavasoglu I Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306 [No Abstract] [Full Text] [Related]
7. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. Juurlink DN CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021 [No Abstract] [Full Text] [Related]
8. Chloroquine and hydroxychloroquine in covid-19. Ferner RE; Aronson JK BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046 [No Abstract] [Full Text] [Related]
9. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns. Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267 [No Abstract] [Full Text] [Related]
10. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191 [TBL] [Abstract][Full Text] [Related]
11. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? Li C; Cheng G Front Immunol; 2020; 11():1969. PubMed ID: 32849658 [TBL] [Abstract][Full Text] [Related]
12. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis. Das RR; Behera B; Mishra B; Naik SS Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234 [TBL] [Abstract][Full Text] [Related]
14. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406 [No Abstract] [Full Text] [Related]
15. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M; Cao R; Zhang L; Yang X; Liu J; Xu M; Shi Z; Hu Z; Zhong W; Xiao G Cell Res; 2020 Mar; 30(3):269-271. PubMed ID: 32020029 [No Abstract] [Full Text] [Related]
16. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine. Sahraei Z; Shabani M; Shokouhi S; Saffaei A Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152 [No Abstract] [Full Text] [Related]
17. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Kim AHJ; Sparks JA; Liew JW; Putman MS; Berenbaum F; Duarte-García A; Graef ER; Korsten P; Sattui SE; Sirotich E; Ugarte-Gil MF; Webb K; Grainger R; Ann Intern Med; 2020 Jun; 172(12):819-821. PubMed ID: 32227189 [TBL] [Abstract][Full Text] [Related]
18. Chloroquine for COVID-19: rationale, facts, hopes. Cortegiani A; Ippolito M; Ingoglia G; Einav S Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908 [No Abstract] [Full Text] [Related]
19. World War against COVID-19: How strong is our armamentarium? Ramachandran V; Marimuthu RR; Chinnambedu RS Med J Malaysia; 2020 May; 75(3):314-315. PubMed ID: 32467555 [TBL] [Abstract][Full Text] [Related]
20. Of chloroquine and COVID-19. Touret F; de Lamballerie X Antiviral Res; 2020 May; 177():104762. PubMed ID: 32147496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]